The cost of mapping trachoma: data from the Global Trachoma Mapping Project

Background: The Global Trachoma Mapping Project (GTMP) was implemented with the aim of completing the baseline map of trachoma globally. Over 2.6 million people were examined in 1,546 districts across 29 countries between December 2012 and January 2016. The aim of the analysis was to estimate the unit cost and to identify the key cost drivers of trachoma prevalence surveys conducted as part of GTMP. Methodology and principal findings: In-country and global support costs were obtained using GTMP financial records. In-country expenditure was analysed for 1,164 districts across 17 countries. The mean survey cost was $13,113 per district [median:$11,675; IQR=$8,365-$14,618], $17,548 per evaluation unit [median:$15,839; IQR=$10,773-$19,915],$692 per cluster [median:$625; IQR=$452-$847] and $6.0 per person screened [median:$4.9; IQR=$3.7-$7.9]. Survey unit costs varied substantially across settings, and were driven by parameters such as geographic location, demographic characteristics, seasonal effects, and local operational constraints. Analysis by activities showed that fieldwork constituted the largest share of in-country survey costs (73.69%), followed by training of survey teams (11.01%). The main drivers of in-country survey costs were personnel (49.49%) and transportation (43.56%). Global support expenditure for all surveyed districts amounted to $5.1m, which included grant management, epidemiological support, and data stewardship. Conclusion: This study provides the most extensive analysis of the cost of conducting trachoma prevalence surveys to date. The findings can aid planning and budgeting for future trachoma surveys required to measure the impact of trachoma elimination activities. Furthermore, the results of this study can also be used as a cost basis for other disease mapping programmes, where disease or context-specific survey cost data are not available

Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries

BACKGROUND: The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact on clinical presentation in a large sample of patients with retinoblastoma from Africa and Europe. METHODS: A cross-sectional analysis including 518 treatment-naïve patients with retinoblastoma residing in 40 European countries and 1024 treatment-naïve patients with retinoblastoma residing in 43 African countries. RESULTS: Capture rate was 42.2% of expected patients from Africa and 108.8% from Europe. African patients were older (95% CI -12.4 to -5.4, p<0.001), had fewer cases of familial retinoblastoma (95% CI 2.0 to 5.3, p<0.001) and presented with more advanced disease (95% CI 6.0 to 9.8, p<0.001); 43.4% and 15.4% of Africans had extraocular retinoblastoma and distant metastasis at the time of diagnosis, respectively, compared to 2.9% and 1.0% of the Europeans. To reach a retinoblastoma centre, European patients travelled 421.8 km compared to Africans who travelled 185.7 km (p<0.001). On regression analysis, lower-national income level, African residence and older age (p<0.001), but not travel distance (p=0.19), were risk factors for advanced disease. CONCLUSIONS: Fewer than half the expected number of patients with retinoblastoma presented to African referral centres in 2017, suggesting poor awareness or other barriers to access. Despite the relatively shorter distance travelled by African patients, they presented with later-stage disease. Health education about retinoblastoma is needed for carers and health workers in Africa in order to increase capture rate and promote early referral

Abordagem fisioterapêutica no pré-parto: proposta de protocolo e avaliação da dor Physiotherapeutic approach in the pre-partum: proposed protocol and evaluate pain

O objetivo deste estudo foi avaliar os efeitos da abordagem fisioterapêutica no pré-parto e propor um protocolo de intervenção baseado na escala visual analógica (EVA) de dor. Dez parturientes, na primeira fase do trabalho de parto, foram questionadas quanto à dor através da EVA e, com base nas respostas, foi proposto um protocolo, EVA 1-3: cinesioterapia, técnicas respiratórias, relaxamento e estímulo à deambulação; EVA 4-7: massoterapia, técnicas respiratórias, relaxamento e estímulo à deambulação; EVA 8-10: técnicas respiratórias, relaxamento e eletroestimulação nervosa transcutânea. Após as intervenções, as voluntárias foram questionadas novamente através da EVA. Os dados da EVA pré- e pós-intervenção foram submetidos ao teste t pareado, atingindo valor médio de 8,8 pré-intervenção e 8,2 pós-intervenção, sem diferença estatística. Os resultados obtidos por meio da análise quantitativa de dor demonstraram que não houve aumento da mesma até uma hora após a intervenção, fato considerado positivo, uma vez que em função da crescente dilatação é esperado um aumento da dor. O protocolo fisioterapêutico proposto mostrou ser de fácil aplicabilidade, podendo auxiliar o fisioterapeuta na escolha da conduta mais adequada à realidade da sala de pré-parto. A abordagem fisioterapêutica no pré-parto parece interferir positivamente sobre a dor e o desconforto materno no grupo estudado.<br>The aim of this study was to evaluate the effects of physical therapy approach in the antepartum and to propose an intervention protocol based on the visual analogue scale (VAS) of pain. Ten parturients in the first stage of labor were questioned about the pain by VAS. Based on the responses, we proposed a protocol VAS 1-3: kinesiotherapy, breathing techniques, relaxation and stimulation of walking; VAS 4-7: massage therapy, breathing techniques, relaxation and stimulation of walking; VAS 8-10: breathing techniques, relaxation and transcutaneous electrical stimulation. After the intervention, the volunteers were questioned again by VAS. The VAS data pre-and post-intervention were submitted to the paired t test, reaching an average value of 8.8 pre-intervention and 8.2 post-intervention, no statistical difference. The results obtained through quantitative analysis of pain showed no increase of the same until one hour after the intervention, which was considered positive, since due to the increasing expansion is expected to increase the pain. The proposed physical therapy protocol proved easy to apply. It can assist the therapist in choosing the most adequate to the reality of pre-delivery room. The physical therapy approach in the pre-partum seems to positively affect pain and maternal discomfort in the study group

Evaluating the Business Case for Continuous Manufacturing of Pharmaceuticals: A Supply Network perspective

This chapter addresses the challenges of evaluating the business case for continuous manufacturing of pharmaceuticals, looking beyond traditional technical assessments made at the unit operations or individual production facility level. It provides an overview of key concepts, approaches and tools for the early assessment of supply network configuration opportunities enabled by continuous production processing interventions. Multiple levels of analysis are considered with the aid of examples based on major UK research programmes on continuous production process technologies. Particular emphasis is placed on the potential for achieving enhanced product flexibility (in terms of volume and variety) and depending on scale, the optimum number and location of manufacturing operations to support speed to market and system-level cost benefits. In the case of multiple manufacturing operations using continuous production process technologies, where production facility replication through digital twins is becoming a key enabler, the chapter sets out a supply network design and analysis approach that evaluates the commercial and operational viability of alternative manufacturing supply network scenarios